Showing posts with label pharmaceuticals. Show all posts
Showing posts with label pharmaceuticals. Show all posts
Tuesday, 8 August 2023

Bill to Map the United States Pharmaceutical Supply Chain

›
A fair amount of concern has been raised concerning the security of supply chains, including the pharmaceutical supply chain.  U.S. Senator ...
Monday, 22 August 2022

Bipartisan Letter from U.S. Senators on Drug Patent Thickets

›
I n June, U.S. Senators Leahy (Democrat) and Cornyn (Republican) (and others) sent a letter to the United States Patent and Trademark Office...
Wednesday, 3 August 2022

Senator Tillis' New Proposed Patent Eligible Subject Matter Legislation

›
Senator Thom Tillis has been busy.  He has proposed a new act to clarify patent eligibility doctrine in the United States.  This is definite...
Sunday, 9 May 2021

It is simplistic and short-sighted to undermine Covid-19 patent rights

›
President Biden’s administration is making a major mistake by its top trade advisor, Katherine Tai, advocating a waiver of patent rights for...
Tuesday, 1 September 2020

Trump to Push Pharma on Drug Pricing

›
President Trump is continuing his push to fulfill campaign promises.  Apparently, he is meeting with pharmaceutical companies this week to ...
Friday, 10 July 2020

New US $1 Billion Fund to Finance Development of Antibiotics

›
The Biotechnology Innovation Organization has issued a press release announcing the creation of essentially a US $1 billion fund to finance...
Monday, 29 June 2020

Gilead Sciences Releases Letter on Pandemic Pricing of COVID-19 Treatment

›
The Chairman and CEO of Gilead Sciences, Daniel O’Day, has released an open letter concerning the pricing of the COVID-19 treatment remde...
Thursday, 7 May 2020

The Pandemic Anti-Monopoly Act to be Introduced in US Congress

›
U.S. Representative Ocasio-Cortez and Senator Warren will introduce the “Pandemic Anti-Monopoly Act” (Act.)  The Act would apparently halt ...

New U.S. Legislation Introduced to Address COVID-19-related Pharmaceutical Manufacturing

›
U.S. Senator Warren, has introduced legislation titled, “COVID-19 Emergency Manufacturing Act” (Act).  The Act gives the federal government...
Friday, 1 May 2020

American Antitrust Institute Adds Voice to Criticism of Lax Competition Law Enforcement in the United States

›
The American Antitrust Institute has released a report titled, “The State of Antitrust Enforcement and Competition in the United States” ...
Monday, 30 March 2020

Novartis, the Good Samaritan

›
As discussed in a previous post , the Covid-19 pandemic is an excellent opportunity for the pharmaceutical industry to demonstrate its commi...
1 comment:
Monday, 16 March 2020

Legislation Introduced to Raise Manufacturing of Active Pharmaceutical Ingredients in the United States

›
On March 11, 2020, Senators Blackburn and Menendez introduced a bill, Securing America’s Medicine Cabinet, designed to raise the manufact...
Monday, 17 February 2020

State of California and Others to Manufacture Generic Drugs

›
In a bid to lower drug prices in California, Governor Gavin Newsom has proposed that the state of California create its own generic drug ...
Thursday, 21 February 2019

Heavily Taxing Billionaires to Promote Innovation

›
An important issue confronting the world concerns the high concentration of wealth and redistribution of that wealth through the tax syste...
Wednesday, 30 January 2019

U.S. State Wants to Adopt "Netflix" Model for Paying for Pharmaceuticals

›
The state of Louisiana is attempting to adopt the Netflix model of paying for pharmaceuticals as a way to tackle the high cost of pharma...
Saturday, 4 August 2018

Bloomberg Tracking Pharmaceutical Prices

›
One way the Trump Administration appears to attempt to control drug prices is through use of the “bully pulpit.”   Wikipedia states that...
Friday, 20 July 2018

New Trump Administration U.S. FDA Working Group on Importation of Pharmaceuticals

›
The U.S. Secretary of the Department of Health and Human Services, Alex Azar, has recently directed the Food and Drug Administration (FDA) C...
Thursday, 21 June 2018

Disincentivizing the Use of IPRs and PGRs Against Pharmaceutical and Biologic Patents

›
Senator Orrin Hatch has introduced legislation designed to curb the use of IPRs and PGRs against pharmaceutical and biologic patents by es...
Wednesday, 4 April 2018

The Importance of an Accurate Assessment of Patent Valuation and Potential Market

›
A recent article in the Saint Louis Post Dispatch by Christopher Yasiejeko describes a patent-related dispute between two academic inst...
Wednesday, 28 February 2018

Professor Margaret Kyle on Whether Pharmaceutical Innovations are Rewarded

›
Our friends at Oxfirst are hosting another interesting webinar on March 14, 2018 at 15.00 BST and 16.00 CET.   The webinar is titled, “A...